Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
3 hedge funds and large institutions have $4.61M invested in Abeona Therapeutics Inc Warrant in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
6% less capital invested
Capital invested by funds: $4.91M → $4.61M (-$296K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.69K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $3.78M | – | – | – |
|
|
SFM
2
Soros Fund Management
New York
| $830K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | +$2.69K | +800 | New |
|
ABEOW Hedge Fund Activity: Q4 2016 in Review
3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2016, worth a combined $4.61M — down 6% from $4.91M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ABEOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $2.69K.
- 3 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2016, up from 2 in Q3 2016.
- Funds reported $4.61M of Abeona Therapeutics Inc Warrant stock for Q4 2016, down 6% quarter-over-quarter.
- 1 fund opened new Abeona Therapeutics Inc Warrant positions in Q4 2016 and 0 closed out, a net change of +1 holder.
- The largest Abeona Therapeutics Inc Warrant buyer in Q4 2016 was UBS Group, an estimated $2.69K added.
Based on aggregated 13F filings for Q4 2016.